相关实验视频
Updated: May 31, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
26
胃潰瘍疾病:常規治療和草本治療的全面評論
Vijay Kumar1, Vrinda Goel1, Sakshi Bajaj1
1Ch. Devi Lal College of Pharmacy, Jagadhri, Yamuna Nagar, 135003, Haryana, India.
Current drug discovery technologies
|January 23, 2025
概括
研究了胃潰瘍疾病 (PUD) 治療方法,將藥品與有前途的草藥療法比作,如Citrus maxima. 结合这些方法可能会为PUD提供更有效,多途径的治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 植物疗法 植物疗法
背景情况:
- 胃潰瘍疾病 (PUD) 仍然是全球重大健康問題,每年影響數百萬人.
- 目前的PUD治疗依赖于抗生素,质子抑制剂 (PPI) 和H2受体对抗剂等药物,严重病例需要手术.
研究的目的:
- 调查PUD的传统和草药治疗方法.
- 评估PUD联合疗法的疗效,作用机制和潜在的协同效应.
主要方法:
- 审查现有的关于药物和植物治疗方法的文献对PUD.
- 对药用植物的功能性,抗氧化,抗炎和细胞保护性质的分析,包括最大 (Pomelo).
主要成果:
- 草药治疗 (植物疗法) 显示出在管理PUD症状和促进愈合方面的潜力.
- 果最大表现出对PUD有益的功能和抗氧化特性.
- 药用植物具有抗炎和细胞保护性质,可以向多种致病途径.
结论:
- 植物疗法为PUD管理提供了一个有前途的补充或替代策略.
- 将草药与传统疗法结合起来,可以为PUD提供全面的治疗方法.
- 进一步的研究对于阐明草药治疗在PUD治疗中的全部潜力和最佳整合至关重要.
相关概念视频
Peptic Ulcer Disease IV: Management
70
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
70
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
324
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
324
Peptic Ulcer Disease V: Surgical Management and Nursing Care
219
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
219
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
333
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
333
Peptic Ulcer Disease I: Introduction
128
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
128
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
349
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
349

